Özoğul, Ece
Montaner, Anna
Pol, Melina https://orcid.org/0000-0002-4670-4252
Frigola, Gerard https://orcid.org/0000-0001-6794-6456
Balagué, Olga
Syrykh, Charlotte
Bousquets-Muñoz, Pablo https://orcid.org/0000-0002-2969-008X
Royo, Romina
Fontaine, Juliette
Traverse-Glehen, Alexandra
Bühler, Marco M. https://orcid.org/0000-0003-0850-3326
Giudici, Luca
Roncador, Marco
Zenz, Thorsten https://orcid.org/0000-0001-7890-9845
Carras, Sylvain
Valmary-Degano, Severine
de Leval, Laurence https://orcid.org/0000-0003-3994-516X
Bosch-Schips, Jan
Climent, Fina
Salmeron-Villalobos, Julia https://orcid.org/0000-0002-7092-9160
Bashiri, Melika
Ruiz-Gaspà, Silvia
Costa, Dolors
Beà, Sílvia https://orcid.org/0000-0001-7192-2385
Salaverria, Itziar https://orcid.org/0000-0002-2427-9822
Giné, Eva
Quintanilla-Martinez, Leticia
Brousset, Pierre
Raffeld, Mark
Jaffe, Elaine S. https://orcid.org/0000-0003-4632-0301
Puente, Xose S. https://orcid.org/0000-0001-9525-1483
López, Cristina
Nadeu, Ferran https://orcid.org/0000-0003-2910-9440
Campo, Elias https://orcid.org/0000-0001-9850-9793
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PMP21/00015 and PID2021-123054OB-I00)
Estela Matutes Fellowship
Article History
Received: 9 July 2024
Revised: 6 September 2024
Accepted: 13 September 2024
First Online: 23 September 2024
Competing interests
: F.N. received honoraria from Janssen, AbbVie, AstraZeneca, and SOPHiA GENETICS for speaking in educational activities, and research funding from Gilead. E.C. has been a consultant for Takeda; has received honoraria from Janssen, EUSA Pharma and Roche for speaking at educational activities and research funding from AstraZeneca and is an inventor on 2 patents filed by the National Institutes of Health, National Cancer Institute: “Methods for selecting and treating lymphoma types,” licensed to NanoString Technologies, and “Evaluation of MCL and methods related thereof”, not related to this project. F.N. and E.C. licensed the use of the protected IgCaller algorithm for Diagnóstica Longwood. The remaining authors declare no competing financial interests.
: The study was approved by the Ethic Committee of the Hospital Clinic of Barcelona (HCB/2021/1076). Patients had given the informed consent for large scale genomic studies and the use of their samples for research purposes. All methods were performed in accordance with the relevant guidelines and regulations.